IPO Boutique

TransMedics Group, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on TransMedics Group, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
TransMedics Group, Inc.TMDX -
NASDAQ
$15.00-$17.00 $16.00 $20.255.7 million5/2/2019
Morgan Stanley, JP Morgan
Co-Manager(s):
Cowen, Canaccord Genuity
Health Care
Filing(s):

Filed 2019-04-05
Terms Added 2019-04-22



TransMedics Group, Inc. Quote & Chart - Click for current quote - TMDX

About TransMedics Group, Inc. (adapted from TransMedics Group, Inc. prospectus):
They are a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "TMDX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved